BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 37510280)

  • 21. MicroRNAs in prostate cancer: Functional role as biomarkers.
    Kanwal R; Plaga AR; Liu X; Shukla GC; Gupta S
    Cancer Lett; 2017 Oct; 407():9-20. PubMed ID: 28823964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Regulatory Mechanism of miR-574-5p Expression in Cancer.
    Huang W; Zhao Y; Xu Z; Wu X; Qiao M; Zhu Z; Zhao Z
    Biomolecules; 2022 Dec; 13(1):. PubMed ID: 36671425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of candidate miRNA biomarkers from miRNA regulatory network with application to prostate cancer.
    Zhang W; Zang J; Jing X; Sun Z; Yan W; Yang D; Shen B; Guo F
    J Transl Med; 2014 Mar; 12():66. PubMed ID: 24618011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The crosstalk between miRNAs and signaling pathways in human cancers: Potential therapeutic implications.
    Shekhar R; Kumari S; Vergish S; Tripathi P
    Int Rev Cell Mol Biol; 2024; 386():133-165. PubMed ID: 38782498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-Based Biomarkers in Lung Cancer: Recent Advances and Potential Applications.
    Shanehbandi D; Asadi M; Seyedrezazadeh E; Zafari V; Shekari N; Akbari M; Rahbarnia L; Zarredar H
    Curr Mol Med; 2023 May; 23(7):648-667. PubMed ID: 35619321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies.
    Corsini LR; Bronte G; Terrasi M; Amodeo V; Fanale D; Fiorentino E; Cicero G; Bazan V; Russo A
    Expert Opin Ther Targets; 2012 Apr; 16 Suppl 2():S103-9. PubMed ID: 22443195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A step-by-step microRNA guide to cancer development and metastasis.
    Markopoulos GS; Roupakia E; Tokamani M; Chavdoula E; Hatziapostolou M; Polytarchou C; Marcu KB; Papavassiliou AG; Sandaltzopoulos R; Kolettas E
    Cell Oncol (Dordr); 2017 Aug; 40(4):303-339. PubMed ID: 28748501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potentials of lncRNA-miRNA-mRNA networks as biomarkers for laryngeal squamous cell carcinoma.
    Lv Y; Wang Y; Zhang Z
    Hum Cell; 2023 Jan; 36(1):76-97. PubMed ID: 36181662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical implications of microRNAs in cancer.
    Bovell LC; Putcha BD; Samuel T; Manne U
    Biotech Histochem; 2013 Oct; 88(7):388-96. PubMed ID: 23647010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNAs and cancer; an overview.
    Tutar L; Tutar E; Tutar Y
    Curr Pharm Biotechnol; 2014; 15(5):430-7. PubMed ID: 24846068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MiRNA-BD: an evidence-based bioinformatics model and software tool for microRNA biomarker discovery.
    Lin Y; Wu W; Sun Z; Shen L; Shen B
    RNA Biol; 2018; 15(8):1093-1105. PubMed ID: 30081733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential role of miR-100 in cancer diagnosis, prognosis, and therapy.
    Qin C; Huang RY; Wang ZX
    Tumour Biol; 2015 Mar; 36(3):1403-9. PubMed ID: 25740059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNAs as biomarkers and therapeutic drugs in human cancer.
    Osaki M; Takeshita F; Ochiya T
    Biomarkers; 2008 Nov; 13(7):658-70. PubMed ID: 19096960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNAs in personalized cancer therapy.
    Sethi S; Ali S; Sethi S; Sarkar FH
    Clin Genet; 2014 Jul; 86(1):68-73. PubMed ID: 24635652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Secretory miRNAs as novel cancer biomarkers.
    Zhang J; Zhao H; Gao Y; Zhang W
    Biochim Biophys Acta; 2012 Aug; 1826(1):32-43. PubMed ID: 22440944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cluster miRNAs and cancer: Diagnostic, prognostic and therapeutic opportunities.
    Kabekkodu SP; Shukla V; Varghese VK; Adiga D; Vethil Jishnu P; Chakrabarty S; Satyamoorthy K
    Wiley Interdiscip Rev RNA; 2020 Mar; 11(2):e1563. PubMed ID: 31436881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Roles of microRNAs as non-invasive biomarker and therapeutic target in colorectal cancer.
    Wan TM; Iyer DN; Ng L
    Histol Histopathol; 2020 Mar; 35(3):225-237. PubMed ID: 31617575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-939, as an important regulator in various cancers pathogenesis, has diagnostic, prognostic, and therapeutic values: a review.
    Kouchaki H; Kamyab P; Darbeheshti F; Gharezade A; Fouladseresht H; Tabrizi R
    J Egypt Natl Canc Inst; 2024 Apr; 36(1):16. PubMed ID: 38679648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating microRNAs: potential biomarkers for common malignancies.
    Khoury S; Tran N
    Biomark Med; 2015; 9(2):131-51. PubMed ID: 25689901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [MicroRNA in Various Aspects of Cancer Development].
    Nambara S; Mimori K
    Gan To Kagaku Ryoho; 2017 May; 44(5):362-366. PubMed ID: 28536328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.